Hypoxia-activated 2-nitroimidazole-brusatol carbonate prodrugs for enhanced gastric cancer therapy with reduced systemic toxicity.
- DOI
- 10.1016/j.bmc.2026.118812
- Published
- 2026 Dec
- Container
- Bioorganic & medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bmc.2026.118812,
title = {Hypoxia-activated 2-nitroimidazole-brusatol carbonate prodrugs for enhanced gastric cancer therapy with reduced systemic toxicity.},
author = {Li J and Ma X and Liu Z and Chang X and Wei Y and Ma N and Liu X and Zhang X and Sun Y and Zhou H and Liu Q and Song SJ},
year = {2026},
journal = {Bioorganic \& medicinal chemistry},
doi = {10.1016/j.bmc.2026.118812},
url = {https://doi.org/10.1016/j.bmc.2026.118812}
}RIS
TY - JOUR TI - Hypoxia-activated 2-nitroimidazole-brusatol carbonate prodrugs for enhanced gastric cancer therapy with reduced systemic toxicity. AU - Li J AU - Ma X AU - Liu Z AU - Chang X AU - Wei Y AU - Ma N AU - Liu X AU - Zhang X AU - Sun Y AU - Zhou H AU - Liu Q AU - Song SJ PY - 2026 JO - Bioorganic & medicinal chemistry DO - 10.1016/j.bmc.2026.118812 UR - https://doi.org/10.1016/j.bmc.2026.118812 ER -
APA
J, L., X, M., Z, L., X, C., Y, W., N, M., X, L., X, Z., Y, S., H, Z., Q, L., & SJ, S. (2026). Hypoxia-activated 2-nitroimidazole-brusatol carbonate prodrugs for enhanced gastric cancer therapy with reduced systemic toxicity.. Bioorganic & medicinal chemistry. https://doi.org/10.1016/j.bmc.2026.118812
Source records
- pubmed · retrieved 2026-11-10T11:59:08.399Z